CANDRIAM S.C.A. – Cerevel Therapeutics Holdings, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$11.22M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+6.88%
quarter
Cerevel Therapeutics Holdings, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 724K | $28.26 | 397.22K | |
| Q2 2022 | share | Increase | +57.87% | 145.60K shares | 1.69M | $26.44 | 397.22K |
| Q1 2022 | share | Increase | +138.28% | 146.01K shares | 5.38M | $35.01 | 251.61K |
| Q4 2021 | share | Increase | 0.00% | 105.59K shares | 3.42M | $32.93 | 105.59K |